Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
基本信息
- 批准号:9754184
- 负责人:
- 金额:$ 28.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-10 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgingAlzheimer&aposs DiseaseBindingCardiovascular DiseasesCatalytic DomainCell CycleCell NucleusCell physiologyCellsChromatinChronic DiseaseComplexCytoplasmCytoplasmic ProteinDNADNA BindingDNA MethylationDNA Modification MethylasesDNA-Binding ProteinsDNA-Directed RNA PolymeraseDataDiabetes MellitusDiseaseEatingEnzymesEpigenetic ProcessEtiologyGene ExpressionGenesGenetic TranscriptionGlucoseGoalsHeat-Shock ResponseHistonesHoloenzymesHumanKineticsLengthLifeLymphocyte ActivationMalignant NeoplasmsMammalsMediatingMethodsMitochondrial ProteinsModificationMolecularNerve DegenerationNuclear ProteinNuclear ProteinsNutrientO-GlcNAc transferasePaperPeptidesPhosphorylationPhosphotransferasesPlantsPlayPost-Translational Protein ProcessingPropertyProtein MicrochipsProteinsProteomicsRNA Polymerase IIRegulationRoleSignal TransductionSiteSpecificityStimulusStressSubstrate SpecificityTAF1 geneTATA-Box Binding ProteinTherapeuticToxic effectTranscriptional RegulationWorkblood glucose regulationcircadian pacemakerin vivoinsightknock-downmutantoverexpressionpromoterprotein Bprotein aminoacid sequenceresponsesensorstoichiometrysugartherapeutic developmenttraffickingtranscription factortranscription factor S-II
项目摘要
The cycling of N-acetylglucosamine on Ser(Thr) residues (O-GlcNAcylation) of nuclear, cytoplasmic and
mitochondrial proteins serves as a nutrient sensor to regulate signaling, transcription, and cellular
physiology. Abnormal O-GlcNAcylation underlies the etiology of diabetes, cancer and Alzheimer's disease.
O-GlcNAcylation regulates nearly every aspect of transcription, including RNA polymerase II, histones, DNA
methyltransferases, and nearly all transcription factors. Yet we know very little about the mechanisms
involved. TATA-binding protein (TBP) is amongst the most important components of the transcription
machinery. Our recent studies indicate that TBP regulated by O-GlcNAcylation in response to nutrients.
O-GlcNAcylation has extensive crosstalk with protein phosphorylation and other modifications. However,
unlike phosphorylation, which is catalyzed by hundreds of kinases, there is only one highly conserved gene
encoding O-GlcNAc transferase (OGT). Nonetheless, OGT site-specifically modifies thousands of proteins.
Our data indicate that OGT's substrate specificity is not only determined by its specificity for peptide
sequence, but also by its transient associations with other proteins, which dynamically target it to specific
substrates. OGT targeting interactions are largely mediated by its tetratricopeptide repeats (TPRs). OGT
missing TPRs remains active against small peptides, but has poor activity against full-length proteins.
Herein we will investigate two major questions related to O-GlcNAcylation: Specific Aim 1: Continue to
Study Glucose Regulation of TATA-binding protein (TBP) via its O-GlcNAcylation. Hypothesis: At
certain promoters, glucose regulates TBP DNA-binding and its ability to bend DNA by altering its O-
GlcNAcylation. We will systematically elucidate mechanisms and functions of this nutrient regulation of TBP.
Three goals: A. Roles of O-GlcNAcylation in the molecular and cellular properties of TBP? B. Roles of O-
GlcNAc in TBP's Interactions in the Transcription Cycle. C. O-GlcNAc's In Vivo Roles in TBP-mediated
Gene Expression. Specific Aim 2: Continue to Elucidate How OGT is Specifically Targeted to
Thousands of Different Protein Substrates? Hypothesis: OGT achieves a high degree of specificity not
only by its recognition of peptide sequence, but also by it being targeted to substrates by accessory
proteins. This Aim will systematically evaluate both the general and specific roles of OGT binding partners
in OGT's activities toward its many substrates.
Given O-GlcNAc's importance to mechanisms of chronic disease, such as glucose toxicity in diabetes,
cancer and neurodegeneration, elucidation of these mechanisms will not only be key to understanding
transcription and signaling, also to uncovering new avenues for therapeutics.
N-乙酰葡萄糖在核,细胞质和
线粒体蛋白是一种营养传感器,可调节信号传导,转录和细胞
生理。异常的O-Glcnacylation是糖尿病,癌症和阿尔茨海默氏病的病因。
O-Glcnacylation几乎调节转录的每个方面,包括RNA聚合酶II,组蛋白,DNA
甲基转移酶和几乎所有转录因子。但是我们对机制知之甚少
涉及。塔塔结合蛋白(TBP)是转录最重要的组成部分之一
机械。我们最近的研究表明,由O-Glcnacylation响应营养的TBP。
O-Glcnacylation具有广泛的串扰,并具有蛋白质磷酸化和其他修饰。然而,
与数百种激酶催化的磷酸化不同,只有一个高度保守的基因
编码O-GLCNAC转移酶(OGT)。尽管如此,OGT位点特异性地修饰了数千种蛋白质。
我们的数据表明,OGT的底物特异性不仅取决于其对肽的特异性
序列,也是通过其与其他蛋白质的瞬时关联,将其动态靶向特定
基材。 OGT靶向相互作用在很大程度上是由其四肽重复序列(TPRS)介导的。 OGT
缺失的TPR对小肽保持活跃,但对全长蛋白的活性较差。
在此,我们将调查与O-Glcnacylation有关的两个主要问题:特定目的1:继续
研究通过其O-Glcnacylation对TATA结合蛋白(TBP)的葡萄糖调节。假设:at
某些启动子,葡萄糖调节TBP DNA结合及其通过改变其O-的弯曲DNA的能力
Glcnacylation。我们将系统地阐明TBP的营养调节的机制和功能。
三个目标:A。O-glcnacylation在TBP的分子和细胞特性中的作用? B. O-的角色
TBP在转录周期中的相互作用中的GlcNAC。 C. O-GLCNAC在TBP介导的体内角色
基因表达。特定目标2:继续阐明OGT专门针对的方式
数千种不同的蛋白质底物?假设:OGT实现高度特异性而不是
仅通过识别肽序列的识别,也仅通过将其靶向粘液材料。
蛋白质。这个目标将系统地评估OGT绑定伙伴的一般和特定角色
在OGT对其许多底物的活动中。
考虑到O-GLCNAC对慢性疾病机制的重要性,例如糖尿病中的葡萄糖毒性,
癌症和神经变性,阐明这些机制不仅是理解的关键
转录和信号传导,也可以发现治疗疗法的新途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD Warren HART其他文献
GERALD Warren HART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD Warren HART', 18)}}的其他基金
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
O-GlcNAc 翻译调节 - 重新提交 03-05-2020
- 批准号:
10308411 - 财政年份:2020
- 资助金额:
$ 28.88万 - 项目类别:
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
O-GlcNAc 的翻译调节 - 重新提交 03-05-2020
- 批准号:
10533317 - 财政年份:2020
- 资助金额:
$ 28.88万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10458006 - 财政年份:2016
- 资助金额:
$ 28.88万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10261390 - 财政年份:2016
- 资助金额:
$ 28.88万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10668984 - 财政年份:2016
- 资助金额:
$ 28.88万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
9329448 - 财政年份:2016
- 资助金额:
$ 28.88万 - 项目类别:
相似国自然基金
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Towards the discovery of Nurr1-RXR modulators
致力于发现 Nurr1-RXR 调制器
- 批准号:
10750409 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别: